Lupin’s Joint Airways Initiative surpasses 10,000 patients

28 Sep 2023 Evaluate

Lupin’s digital asthma educator platform -- Joint Airways Initiative (JAI), has now onboarded over 10,000 patients since its launch. JAI, a visionary initiative by Lupin, equips patients with the knowledge and skills to manage their condition effectively. By offering a comprehensive range of services, including personalized inhalation technique guidance, pulmonary physiotherapy, dietary counselling, yoga, and medication adherence, JAI is committed to enhancing treatment outcomes and overall well-being. This is India’s first digital asthma educator platform.

As per the Global Asthma Report 2022, 35 million Indians suffer from asthma and COPD, with less than 30% of them being aware of their condition. 90% of those diagnosed utilize their inhalers incorrectly, adversely impacting their treatment progress and overall health. JAI has bridged this gap by providing personalized, one-on-one training sessions to over 10,000 onboarded patients from qualified asthma educators on correct inhalation techniques.

Lupin is an innovation led transnational pharmaceutical company producing, developing and marketing a wide range of branded and generic formulations, biotechnology products and active pharmaceutical ingredients (APIs) globally.

Lupin Share Price

2103.30 -8.70 (-0.41%)
01-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1720.40
Dr. Reddys Lab 1253.60
Cipla 1500.10
Zydus Lifesciences 914.50
Lupin 2103.30
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×